New Jersey announces plans to allocate $5 million in funding from cannabis revenue towards Community-Based Violence Intervention (CBVI) programs throughout the state.
In a recent press release (1), New Jersey Governor Phil Murphy and Attorney General Matthew J. Platkin announced that $15 million would be made available through a competitive grant process to support Community-Based Violence Intervention (CBVI) Programs throughout the state. According to the announcement (1), funding for this initiative will be provided through the Fiscal Year 2024 Appropriations Act, and includes $5 million from the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Fund which is dedicated to reinvestment in communities most impacted by cannabis criminalization.
NJ’s CBVI programs use interventions and protective activities in communities and among populations associated with risk factors for exposure to violence. CBVI initiatives reportedly include a range of strategies such as mentoring programs, street outreach, trauma support services, de-escalation, targeted afterschool programs, job training, and more.
“Keeping New Jersey’s residents safe is my top priority. Our comprehensive approach to public safety focuses support for community-led violence intervention efforts that are disrupting cycles of violence at the ground level,” said Attorney General Platkin in the press release (1). “Thanks to the leadership and support of Governor Murphy, we are continuing the State’s historic investment and commitment to this essential work. These funds continue to put resources in the hands of grass roots organizations so that communities are part of our public safety mission.”
According to a recent article from Marijuana Moment (2), New Jersey as well as many other states with legal cannabis route at least some portion of revenue toward community reinvestment. California, Illinois, and Arizona all recently announced plans to allocate money from cannabis revenue back to local communities.
California announced it was opening applications for $48 million in cannabis tax-funded community reinvestment grants, such as support job placement, legal assistance, treatment of mental health and substance use disorders, referrals to medical care, and other services for communities that have been disproportionately affected by the drug war (2). California regulators at the Department of Cannabis Control (DCC) also recently announced the award of $4.1 million to 18 local governments through a first-of-its-kind program to support cannabis business licensing programs and curb the illicit market. The DCC also recently awarded recently awarded almost $20 million in research grants, funded by marijuana tax revenue, to 16 academic institutions to carry out studies into cannabis.
Illinois paid out $45 million in grants in 2022 under its Restore, Reinvest, and Renew (R3) program, which was established under the state’s adult-use cannabis legalization law (2). Arizona sets aside 10% of cannabis tax revenue for a justice redevelopment fund, which funds public health services, counseling, job training, and other social services for communities that have been adversely affected by marijuana arrests and criminalization (2).
References
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.